Hakutulokset - Isabelle Bedrosian

Tarkenna hakua
  1. 1
    Contralateral prophylactic mastectomy: current perspectives

    Contralateral prophylactic mastectomy: current perspectives Tekijä Katharine Yao, Mark Sisco, Isabelle Bedrosian

    Julkaistu 2016
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Population-Based Study of Contralateral Prophylactic Mastectomy and Survival Outcomes of Breast Cancer Patients

    Population-Based Study of Contralateral Prophylactic Mastectomy and Survival Outcomes of Breast Cancer Patients Tekijä Isabelle Bedrosian, Che‐Yuan Hu, G. J. Chang

    Julkaistu 2010
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    The isomiR-140-3p-regulated mevalonic acid pathway as a potential target for prevention of triple negative breast cancer

    The isomiR-140-3p-regulated mevalonic acid pathway as a potential target for prevention of triple negative breast cancer Tekijä Anjana Bhardwaj, Harpreet Singh, Celestine Trinidad, Constance T. Albarracin, Kelly K. Hunt, Isabelle Bedrosian

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    Outcomes after Treatment of Metaplastic Versus Other Breast Cancer Subtypes

    Outcomes after Treatment of Metaplastic Versus Other Breast Cancer Subtypes Tekijä Amy C. Moreno, Yan Lin, Isabelle Bedrosian, Yu Shen, Gildy V. Babiera, Simona F. Shaitelman

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Underuse of Trimodality Treatment Affects Survival for Patients With Inflammatory Breast Cancer: An Analysis of Treatment and Survival Trends From the National Cancer Database

    Underuse of Trimodality Treatment Affects Survival for Patients With Inflammatory Breast Cancer: An Analysis of Treatment and Survival Trends From the National Cancer Database Tekijä Natasha M. Rueth, Heather Lin, Isabelle Bedrosian, Simona F. Shaitelman, Naoto T. Ueno, Yu Shen, Gildy V. Babiera

    Julkaistu 2014
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    Lumpectomy Plus Hormone or Radiation Therapy Alone for Women Aged 70 Years or Older With Hormone Receptor–Positive Early Stage Breast Cancer in the Modern Era: An Analysis of the National Cancer Database

    Lumpectomy Plus Hormone or Radiation Therapy Alone for Women Aged 70 Years or Older With Hormone Receptor–Positive Early Stage Breast Cancer in the Modern Era: An Analysis of the N... Tekijä Samantha M. Buszek, Heather Lin, Isabelle Bedrosian, Nina Tamirisa, Gildy V. Babiera, Yu Shen, Simona F. Shaitelman

    Julkaistu 2019
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    Long-Term Safety of Observation in Selected Women Following Core Biopsy Diagnosis of Atypical Ductal Hyperplasia

    Long-Term Safety of Observation in Selected Women Following Core Biopsy Diagnosis of Atypical Ductal Hyperplasia Tekijä Rhiana Menen, Nivetha Ganesan, Therese B. Bevers, Binwu Ying, Robin Coyne, Deanna L. Lane, Constance T. Albarracin, Isabelle Bedrosian

    Julkaistu 2016
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Regulation of miRNA-29c and its downstream pathways in preneoplastic progression of triple-negative breast cancer

    Regulation of miRNA-29c and its downstream pathways in preneoplastic progression of triple-negative breast cancer Tekijä Anjana Bhardwaj, Harpreet Singh, Kimal Rajapakshe, Kazunoshin Tachibana, Nivetha Ganesan, Yinghong Pan, Preethi H. Gunaratne, Cristian Coarfa, Isabelle Bedrosian

    Julkaistu 2017
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    Association of Chemotherapy With Survival in Elderly Patients With Multiple Comorbidities and Estrogen Receptor–Positive, Node-Positive Breast Cancer

    Association of Chemotherapy With Survival in Elderly Patients With Multiple Comorbidities and Estrogen Receptor–Positive, Node-Positive Breast Cancer Tekijä Nina Tamirisa, Heather Lin, Yu Shen, Simona F. Shaitelman, Meghan Karuturi, Sharon H. Giordano, Gildy V. Babiera, Isabelle Bedrosian

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    Disparities in the Use of Breast-Conserving Therapy Among Patients With Early-Stage Breast Cancer

    Disparities in the Use of Breast-Conserving Therapy Among Patients With Early-Stage Breast Cancer Tekijä Meeghan A. Lautner, Heather Lin, Yu Shen, Catherine Parker, Henry M. Kuerer, Simona F. Shaitelman, Gildy V. Babiera, Isabelle Bedrosian

    Julkaistu 2015
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    Use of Sentinel Lymph Node Dissection After Neoadjuvant Chemotherapy in Patients with Node-Positive Breast Cancer at Diagnosis: Practice Patterns of American Society of Breast Surgeons Members

    Use of Sentinel Lymph Node Dissection After Neoadjuvant Chemotherapy in Patients with Node-Positive Breast Cancer at Diagnosis: Practice Patterns of American Society of Breast Surg... Tekijä Abigail S. Caudle, Isabelle Bedrosian, Denái R. Milton, Sarah M. DeSnyder, Henry M. Kuerer, Kelly K. Hunt, Elizabeth A. Mittendorf

    Julkaistu 2017
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer

    HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer Tekijä Julie E. Lang, Kailash Mosalpuria, Massimo Cristofanilli, Savitri Krishnamurthy, James M. Reuben, Balraj Singh, Isabelle Bedrosian, Funda Meric‐Bernstam, Anthony Lucci

    Julkaistu 2008
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status

    Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status Tekijä Abenaa M. Brewster, Isabelle Bedrosian, Patricia A. Parker, Wenli Dong, Susan K. Peterson, Scott B. Cantor, Melissa A. Crosby, Yu Shen

    Julkaistu 2012
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients

    A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients Tekijä Isabelle Bedrosian, Gildy V. Babiera, Elizabeth A. Mittendorf, Henry M. Kuerer, Laura Pantoja, Kelly K. Hunt, Savitri Krishnamurthy, Funda Meric‐Bernstam

    Julkaistu 2010
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    Rapid High Efficiency Sensitization of CD8+ T Cells to Tumor Antigens by Dendritic Cells Leads to Enhanced Functional Avidity and Direct Tumor Recognition Through an IL-12-Dependent Mechanism

    Rapid High Efficiency Sensitization of CD8+ T Cells to Tumor Antigens by Dendritic Cells Leads to Enhanced Functional Avidity and Direct Tumor Recognition Through an IL-12-Dependen... Tekijä Shuwen Xu, Gary K. Koski, Mark B. Faries, Isabelle Bedrosian, Rosemarie Mick, Markus Maeurer, Martin A. Cheever, Peter A. Cohen, Brian J. Czerniecki

    Julkaistu 2003
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    Impact of the American College of Surgeons Oncology Group Z0011 Criteria Applied to a Contemporary Patient Population

    Impact of the American College of Surgeons Oncology Group Z0011 Criteria Applied to a Contemporary Patient Population Tekijä Min Yi, Henry M. Kuerer, Elizabeth A. Mittendorf, Rosa F. Hwang, Abigail S. Caudle, Isabelle Bedrosian, Funda Meric‐Bernstam, Jamie L. Wagner, Kelly K. Hunt

    Julkaistu 2012
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    High incidence of germline <i>BRCA</i> mutation in patients with ER low‐positive/PR low‐positive/HER‐2 <i>neu</i> negative tumors

    High incidence of germline <i>BRCA</i> mutation in patients with ER low‐positive/PR low‐positive/HER‐2 <i>neu</i> negative tumors Tekijä Rachel Sanford, Juhee Song, Angelica M. Gutierrez‐Barrera, Jessica Profato, Ashley Woodson, Jennifer K. Litton, Isabelle Bedrosian, Constance T. Albarracin, Vicente Valero, Banu K. Arun

    Julkaistu 2015
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    Trends in and Outcomes from Sentinel Lymph Node Biopsy (SLNB) Alone vs. SLNB with Axillary Lymph Node Dissection for Node-Positive Breast Cancer Patients: Experience from the SEER Database

    Trends in and Outcomes from Sentinel Lymph Node Biopsy (SLNB) Alone vs. SLNB with Axillary Lymph Node Dissection for Node-Positive Breast Cancer Patients: Experience from the SEER... Tekijä Min Yi, Sharon H. Giordano, Funda Meric‐Bernstam, Elizabeth A. Mittendorf, Henry M. Kuerer, Rosa F. Hwang, Isabelle Bedrosian, Loren L. Rourke, Kelly K. Hunt

    Julkaistu 2010
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  19. 19
    Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer

    Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer Tekijä Min Yi, Savitri Krishnamurthy, Henry M. Kuerer, Funda Meric‐Bernstam, Isabelle Bedrosian, Merrick I. Ross, Frederick C. Ames, Anthony Lucci, Rosa F. Hwang, Kelly K. Hunt

    Julkaistu 2008
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  20. 20
    Evaluation of a Breast Cancer Nomogram for Predicting Risk of Ipsilateral Breast Tumor Recurrences in Patients With Ductal Carcinoma in Situ After Local Excision

    Evaluation of a Breast Cancer Nomogram for Predicting Risk of Ipsilateral Breast Tumor Recurrences in Patients With Ductal Carcinoma in Situ After Local Excision Tekijä Min Yi, Funda Meric‐Bernstam, Henry M. Kuerer, Elizabeth A. Mittendorf, Isabelle Bedrosian, Anthony Lucci, Rosa F. Hwang, Jaime R. Crow, Sheng Luo, Kelly K. Hunt

    Julkaistu 2012
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: